PEG300 [25322-68-3]

Katalog-Nummer HY-Y0873-50mL

Size : 50mL

Marke : MedChemExpress

Contact local distributor :


Telefonnummer : +1 850 650 7790

PEG300 (Polyethylene glycol 300), a neutral polymer of molecular weight 300, is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

PEG300 Chemische Struktur

CAS. Nr. : 25322-68-3

Synthetic products have potential research and development risk.

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

  • Signal Transduct Target Ther. 2023 Sep 25;8(1):366.  [Abstract]
  • Cell. 2021 Sep 2;184(18):4753-4771.e27.  [Abstract]
  • Nat Microbiol. 2023 Jan;8(1):121-134.  [Abstract]
  • J Hepatol. 2023 Jan 18;S0168-8278(23)00015-6.  [Abstract]
  • Nat Commun. 2024 Jan 4;15(1):252.  [Abstract]
  • Nat Commun. 2023 May 24;14(1):2994.  [Abstract]
  • Nat Commun. 2023 May 19;14(1):2859.  [Abstract]
  • Nat Commun. 2021 May 10;12(1):2587.  [Abstract]
  • Biomark Res. 2023 Jan 24;11(1):8.  [Abstract]
  • Proc Natl Acad Sci U S A. 2022 Oct 11;119(41):e2203480119.  [Abstract]
  • Cancer Res. 2021 Jan 25;canres.2808.2020.  [Abstract]
  • Cell Commun Signal. 2024 Jan 18;22(1):53.  [Abstract]
  • Cell Rep. 2023 Apr 20;42(5):112424.  [Abstract]
  • Cell Rep. 2023 Mar 30;42(4):112314.  [Abstract]
  • Phytomedicine. 2024 Feb 7, 155425.
  • Hepatol Int. 2024 Jan 3.  [Abstract]
  • Stem Cell Res Ther. 2023 Dec 20;14(1):333.  [Abstract]
  • Liver Int. 2023 Dec 11.  [Abstract]
  • Aging Cell. 2023 Jun 13;e13896.  [Abstract]
  • Neurobiol Dis. 2023 Mar 28;106103.  [Abstract]
  • Phytomedicine. 2022, 154638.
  • Neural Regen Res. 2022.
  • Biomed Pharmacother. 2023, 157: 114030.
  • Biomed Pharmacother. 2022 Sep 13;155:113669.  [Abstract]
  • Food Funct. 2020 Dec 15.
  • Int Immunopharmacol. 2024 Feb 17:130:111680.  [Abstract]
  • Mol Neurobiol. 2023 Nov 13.  [Abstract]
  • Eur J Pharmacol. 2023 Nov 21:176171.  [Abstract]
  • Pestic Biochem Physiol. 2023 Oct 14, 105647.
  • Neurosci Bull. 2023 Jun 15.  [Abstract]
  • Int J Mol Sci. 2023 Jun 9, 24(12), 9954.
  • Int J Obes. 2023 Feb 13;1-10.  [Abstract]
  • Pharmaceuticals. 2023, 16(2), 316.
  • Int Immunopharmacol. 2023, 114: 109607.
  • Bone. 2022 Dec 21;168:116648.  [Abstract]
  • iScience. 13 August 2022, 104936.
  • Int Immunopharmacol. 2022 Jun 28;110:109000.  [Abstract]
  • iScience. 2022 Apr 18;25(5):104267.  [Abstract]
  • Front Pharmacol. 13 September 2021.
  • J Neurochem. 2021 Jul 13.  [Abstract]
  • J Cell Mol Med. 2021 Jun;25(12):5782-5798.  [Abstract]
  • J Ethnopharmacol. 2021, 114078.
  • Addict Biol. 2024 Mar;29(3):e13382.  [Abstract]
  • Heliyon. 2024 Jan 17.
  • Epilepsy Res. 2023 Jul, 193, 107161.
  • Mol Immunol. 2023 Apr 10;157:176-185.  [Abstract]
  • Arch Biochem Biophys. 2022 Jun 21;727:109325.  [Abstract]
  • Front Cardiovasc Med. 2022 Jun 2;9:907747.  [Abstract]
  • Mol Imaging Biol. 2022 Jun 22.  [Abstract]
  • FEBS Open Bio. 2022 Jun 24.  [Abstract]
  • J Pain Res. 2021 Oct 18;14:3289-3299.  [Abstract]
  • bioRxiv. 2024 Mar 8.
  • bioRxiv. 2024 Jan 24.
  • Research Square Preprint. 2023 Dec 1.
  • Western University. 2023 Aug 22.
  • Research Square Preprint. 2023 Sep 8.
  • University of Michigan. 2023 Sep.
  • Research Square Preprint. 2023 Jun 28.
  • Universidad de Granada. 2023 Mar 27.
  • Research Square Print. 2023 Mar 23.
  • Research Square Print. 2022 Aug.
  • Biologische Aktivität

  • Reinheit & Dokumentation

  • Verweise

  • Kundenbewertung

PEG300 (Polyethylene glycol 300), a neutral polymer of molecular weight 300, is a water-soluble, low immunogenic and biocompatible polymer formed by repeating units of ethylene glycol.

In Vitro

The FDA has approved polyethylene glycol (PEG) for use as a vehicle or base in foods, cosmetics and pharmaceuticals, including injectable, topical, rectal and nasal formulations. PEG shows little toxicity, and is eliminated from the body intact by either the kidneys (for PEGs < 30 kDa) or in the faeces (for PEGs > 20 kDa). PEG lacks immunogenicity, and antibodies to PEG are generated in rabbits only if PEG is combined with highly immunogenic proteins.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

  • [1]. J.Billingham, et al. Adsorption of polyamine, polyacrylic acid and polyethylene glycol on montmorillonite: An in situ study using ATR-FTIR. Volume 14, Issue 1, March 1997, Pages 19-34.

    [2]. Lee CC, et al. Structural basis of polyethylene glycol recognition by antibody. J Biomed Sci. 2020 Jan 7;27(1):12.  [Content Brief]

    [3]. Harris JM, et al. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003 Mar;2(3):214-21.  [Content Brief]

    [4]. Xiaoqin Wang, et al. Injectable silk-polyethylene glycol hydrogels. Acta Biomater. 2015 Jan;12:51-61.  [Content Brief]

    [5]. Ellen Weisberg, et al. Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias. Blood. 2007 Mar 1;109(5):2112-20.  [Content Brief]

  • [1]. J.Billingham, et al. Adsorption of polyamine, polyacrylic acid and polyethylene glycol on montmorillonite: An in situ study using ATR-FTIR. Volume 14, Issue 1, March 1997, Pages 19-34.

    [2]. Lee CC, et al. Structural basis of polyethylene glycol recognition by antibody. J Biomed Sci. 2020 Jan 7;27(1):12.

    [3]. Harris JM, et al. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003 Mar;2(3):214-21.

    [4]. Xiaoqin Wang, et al. Injectable silk-polyethylene glycol hydrogels. Acta Biomater. 2015 Jan;12:51-61.

    [5]. Ellen Weisberg, et al. Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias. Blood. 2007 Mar 1;109(5):2112-20.

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
H2O / DMSO 1 mM 3.3333 mL 16.6667 mL 33.3333 mL 83.3333 mL
5 mM 0.6667 mL 3.3333 mL 6.6667 mL 16.6667 mL
10 mM 0.3333 mL 1.6667 mL 3.3333 mL 8.3333 mL
15 mM 0.2222 mL 1.1111 mL 2.2222 mL 5.5556 mL
20 mM 0.1667 mL 0.8333 mL 1.6667 mL 4.1667 mL
25 mM 0.1333 mL 0.6667 mL 1.3333 mL 3.3333 mL
30 mM 0.1111 mL 0.5556 mL 1.1111 mL 2.7778 mL
40 mM 0.0833 mL 0.4167 mL 0.8333 mL 2.0833 mL
50 mM 0.0667 mL 0.3333 mL 0.6667 mL 1.6667 mL
60 mM 0.0556 mL 0.2778 mL 0.5556 mL 1.3889 mL
80 mM 0.0417 mL 0.2083 mL 0.4167 mL 1.0417 mL
100 mM 0.0333 mL 0.1667 mL 0.3333 mL 0.8333 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Others
  • Biochemical Assay Reagents
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

PEG30025322-68-3Polyethylene glycol 300PEG 300PEG-300Polyethylene glycol300Polyethylene glycol-300Biochemical Assay ReagentsimmunogenicbiocompatiblepolymergastrointestinalmarkerInhibitorinhibitorinhibit

Ihre kürzlich angesehenen Produkte:

Online-Anfrage

Your information is safe with us. * Required Fields.

Massenanfrage

Inquiry Information

Produktname:
PEG300
Art. -Nr.:
HY-Y0873
Menge:
MCE Japan Authorized Agent:

Sie könnten auch an folgenden Produkten interessiert sein:



Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
011086-5mg
 5mg 
L2050-01B-1mg
 1mg